Novartis AG ADR sell The Goldman Sachs Group, Inc.
Start price
12.09.25
/
50%
€106.50
Target price
12.09.26
€100.61
Performance (%)
4.23%
Price
11:52
€111.00
Summary
This prediction is currently active. With a performance of 4.23%, the SELL prediction by The_Goldman_Sachs_Gr for Novartis AG ADR is trending in the wrong direction This prediction currently runs until 12.09.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novartis AG ADR | 1.852% | 1.852% |
| iShares Core DAX® | -0.230% | -0.593% |
| iShares Nasdaq 100 | -1.780% | 6.137% |
| iShares Nikkei 225® | -2.684% | 9.665% |
| iShares S&P 500 | -0.694% | 4.771% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Novartis AG ADR diskutieren
Novartis (NYSE:NVS) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $118.00 price target on the stock, down previously from $119.00.
Ratings data for NVS provided by MarketBeat